AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Choosing between index funds and ETFs depends on trading needs, costs, and tax considerations. This guide outlines practical decision factors for you.
14,885 articlesAbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
SpaceX begins trading on Nasdaq, positioning Elon Musk for trillionaire status as investors bet on a bold, multi-plan...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
Plans for a UFC event on the White House grounds feature a towering, temporary arena dubbed the Claw Cage. As costs r...
As AI accelerates, energy and data infrastructure firms are in the spotlight. Here are two stock ideas that could rid...
The early 2027 social security outlook points to a higher potential COLA, but gains may still lag behind rising livin...
Missing pet posts are increasingly targeted by AI-powered scammers. Learn how these schemes work, the warning signs, ...
Bland, a San Francisco voice AI startup, raised $50 million in a Series C led by Dell Technologies Capital, defying d...
Retirees are flocking to Clorox as the market bets on continued high yields. The company offers a compelling 5.5% div...
AI sparks a data deluge, and storage stocks ride the wave. This guide breaks down how this storage stock more opportu...
DoorDash has shown impressive revenue gains, but a rising price tag isn’t a guarantee of long-term value. This guide ...
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...